Business Context and Reporting Period
Company: Nephros, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 6, 2019
Reporting Period: Third Quarter of Fiscal Year 2019
This filing serves as a notification that the Company issued a press release disclosing its financial results for the third quarter of fiscal year 2019. The press release is included as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the referenced press release (Exhibit 99.1), which is not included in the input text.
Material Changes
The filing text does not provide specific details on material changes versus the prior comparable period. It only confirms the disclosure of Q3 2019 results.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release containing the Company's financial results but does not include the text of that commentary.
Legal Status of Information: The information in the press release and Item 2.02 is furnished, not "filed," under Section 18 of the Exchange Act and is not subject to liability under that section unless expressly incorporated by reference.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 6, 2019) for specific Q3 2019 revenue, net loss, and cash position figures.
- Verify the Company's liquidity status and runway based on the cash flow data in the press release.
- Check for any updated guidance or clinical trial milestones mentioned in the full press release text.
- Confirm the trading symbol (NEPH) on The Nasdaq Stock Market LLC.